Dr Reddy’s Laboratories has announced that it has secured approval for Clopidogrel, an anti-platelet in China
Drug firm Dr Reddy’s Laboratories said it has received approval for anti-platelet drug Clopidogrel in China.
“The company believes that the sales from this product will not be material in the current financial year, that is 2019-20,” Dr Reddy’s Laboratories said in a regulatory filing.
Clopidogrel is an anti-platelet drug that blocks platelets from sticking together and prevents them from forming harmful clots.
Comments are closed.